Key Metrics
Factor Lens
Seasonal Performance
Dividends
Per-share amounts adjusted for stock splits.
Last 12 Payouts
| Period | Ex-Date | Amount / Share |
|---|---|---|
| ANNC | 2026-08-19 | $0.6600 |
| Q3 2026 | 2026-05-13 | $0.6000 |
| Q4 2025 | ~2026-04-01 | $0.6700 |
| Q2 2025 | 2026-02-11 | $0.6000 |
| Q1 2025 | 2025-11-12 | $0.6000 |
| Q1 2025 | 2025-08-13 | $0.6000 |
| Q3 2025 | 2025-05-07 | $0.5300 |
| Q4 2024 | ~2025-04-01 | $0.5800 |
| Q2 2024 | 2025-02-12 | $0.5300 |
| Q1 2024 | 2024-11-06 | $0.5300 |
| Q1 2024 | 2024-08-14 | $0.5300 |
| Q3 2024 | 2024-05-08 | $0.4800 |
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
ResMed Inc. is a global leader in digital health and cloud-connected medical devices. The company designs innovative technology to empower people to live happier, healthier lives… through artificial intelligence-powered digital health solutions, cloud-connected devices, and intelligent software designed to make home healthcare more personalized, accessible, and effective. The company operates in two segments: (1) Sleep and Breathing Health, which includes CPAP systems for obstructive sleep apnea, bilevel devices, non-invasive and invasive ventilators, high-flow therapy systems, and related accessories and masks for patients with sleep apnea, COPD, and other chronic respiratory diseases; diagnostic products; and connected care cloud-based software platforms including myAir, AirView, and Somnoware; and (2) Residential Care Software, which provides cloud-based health applications and software solutions including Brightree for durable medical equipment providers and MEDIFOX DAN for residential care providers in Germany, as well as the MatrixCare business. The company employs approximately 11,370 people and sells products in more than 140 countries through wholly owned subsidiaries and independent distributors. In June 2026, ResMed acquired Noctrix Health for an FDA De Novo classified device treating restless legs syndrome. The company also operates VirtuOx, an independent diagnostic testing facility acquired in 2025 providing in-home and remote testing services for sleep, respiratory, cardiac, and other health conditions.
- Name
- ResMed Inc.
- Industry
- Medical Devices
- CEO
- Michael Farrell · Chairman of the Board and Chief Executive Officer
- Employees
- 11,370 as of 2026-06-30
- IPO Date
- 2018-05-04
- Phone
- (858) 836-5000
- Address
- 9001 Spectrum Center Blvd., San Diego, CA 92123
- Website
- www.resmed.com
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| Christopher DelOrefice | Director | — |
| Jan De Witte | Director | — |
| Carol Burt | Director | — |
| Peter Farrell | Founder and Chairman Emeritus | — |
| Michael Farrell | Chairman of the Board and Chief Executive Officer | — |
Latest News
- 2026-04-26
- 2026-04-23
- 2026-04-23
- 2026-04-20
-
2026-04-18
Lbp Am Sa Buys 18,142 Shares of ResMed Inc. $RMD defenseworld.net
- 2026-04-17
-
2026-04-11
Michael Farrell Sells 4,991 Shares of ResMed (NYSE:RMD) Stock defenseworld.net
-
2026-04-10
Aaron Wealth Advisors LLC Sells 2,210 Shares of ResMed Inc. $RMD defenseworld.net